Amoebiasis and its control.
- 1 January 1985
- journal article
- Vol. 63 (3), 417-26
Abstract
On a global scale, 480 million people were recently estimated to be infected with Entamoeba histolytica and some 48 million people suffer from invasive amoebiasis. The latter, in the intestinal and extra-intestinal forms, accounts for 40 000 to 110 000 deaths annually. In view of this considerable mortality and morbidity, more research is urgently needed so that more effective control strategies may be introduced.This Update article reviews the magnitude of the problem, clinical and laboratory diagnosis, present treatment and prevention measures, possible control strategies, and research priorities.This publication has 6 references indexed in Scilit:
- Selective Primary Health Care: Strategies for Control of Disease in the Developing World. X. AmebiasisClinical Infectious Diseases, 1983
- A Solid-Phase Sandwich Radioimmunoassay for Entamoeba histolytica Proteins and the Detection of Circulating Antigens in AmoebiasisGastroenterology, 1982
- A Review of the Parasite Cellular Mechanisms Involved in the Pathogenesis of AmebiasisClinical Infectious Diseases, 1982
- BIOCHEMICAL HOMOGENEITY OF ENTAMOEBA HISTOLYTICA ISOLATES, ESPECIALLY THOSE FROM LIVER ABSCESSThe Lancet, 1982
- A pathway for the interconversion of hexose and pentose in the parasitic amoeba Entamoeba histolyticaBiochemical Journal, 1982
- Interaction between Entamoeba histolytica and Human Polymorphonuclear NeutrophilsThe Journal of Infectious Diseases, 1981